Sida 1 från 103 resultat
BACKGROUND OF THE INVENTION
The standard synthesis for pyrazoles involves the reaction of a .beta..epsilon..tau..alpha.-dicarbonyl compound with a hydrazine under mild conditions. See A. R. Katritzky in "The Principles of Heterocyclic Chemistry", Academic Press, New York (1968) at page 139. When the
FIELD OF THE INVENTION
This invention is in the field of anti-inflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major
FIELD OF THE INVENTION
This invention is in the field of anti-inflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major
TECHNICAL FIELD
The present invention relates to novel fused pyrazole derivatives and their pharmaceutically acceptable salts thereof or pharmaceutical compositions comprising these compounds, and to methods of preparing these compounds. The present invention also relates to use of the fused
FIELD OF THE INVENTION
This invention is in the field of anti-inflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major
BACKGROUND OF THE INVENTION
This invention relates to novel anti-inflammatory pyrazole compounds.
SUMMARY OF THE INVENTION
In a compositional aspect, this invention relates to novel pyrazole compounds of Formula I ##STR2## wherein N IS 1, 2, 3, OR 4;
R.sub.1, r.sub.2, r.sub.3, and R.sub.4 each are
FIELD OF THE INVENTION
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major
FIELD OF THE INVENTION
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major
FIELD OF THE INVENTION
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major
FIELD OF THE INVENTION
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major
TECHNICAL FIELD
This invention relates to pyrazole compounds, and their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of this invention have activity as prostaglandin E.sub.2 receptor antagonists, and these are useful in the
BACKGROUND OF THE INVENTION
It has been well established that T-cells play an important role in regulating immune response (F. Powrie and R. L. Coffman, Immunol. Today, 14, p. 270 (1993)). Indeed, activation of T-cells is often the initiating event in many inflammatory and autoimmune diseases. IL-2
BACKGROUND OF THE INVENTION
This invention relates to tricyclic pyrazole derivatives, methods of treatment and pharmaceutical compositions for the treatment of cyclooxygenase mediated diseases. The compounds of this invention inhibit the biosynthesis of prostaglandins by intervention of the action
This invention relates to new heterocyclic compounds, processes for their preparation and compositions containing them.
Chemical Abstracts, Vol 71, 1969, 22058Z describes several 3-aryl-5-methylpyrazol-3-amines but does not disclose any pharmaceutical uses of these compounds.
The Indian Journal of
BACKGROUND OF THE INVENTION
This invention relates to heterocyclo-alkylsulfonyl pyrazoles, methods of treatment and pharmaceutical compositions for the treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer, in mammals, preferably humans, dogs, cats or